For Investors
Strategic Investing in Pharmaceuticals: Our Ready to Sell and Development Projects
Adsidera applies decades of pharmaceutical consulting expertise to develop and commercialize our own healthcare innovation ventures. We don’t just advise – we execute: acquiring licenses, developing products, and building strategic alliances where adsidera drives the brand and operations.
Our Vision
Transforming patients’ health through clinically backed nutraceutical and pharmaceutical solutions
Fertility and Hormonal Health – Supportive Care – Epigenetics
Each project we run demonstrates healthcare innovation and entrepreneurship capabilities and passion through proven regulatory knowledge, market access experience, and commercial execution skills. This dual model – consulting expertise applied to proprietary development – accelerates innovation in healthcare and life sciences industry.
We seek investors who recognize the opportunity in backing a seasoned team with 30+ years executing transformative pharmaceutical projects.
Actions to Date
Strategic Partnership
Exclusive licence in CH (option FR/DE/AT) for commercialization of any existing and/or new nutraceuticals in fertility, hormonal health and any other therapeutic area, whether already sold in Italy or under development by the licensor
Patented Innovative Technology
First-in-class onto the Swiss market enabling rapid and superior absorption of active ingredients with proven health benefits, supported by Clinical Studies
Development & In-licensing
Development and in-licensing plan for new nutraceutical and pharmaceutical products in Fertility, Hormonal Health, Supportive Care, Epigenetics
Expertise
A team of internationally recognized senior experts to manage the existing portfolio and enhance it through development of proprietary products and entry into new areas such as supportive care and epigenetics
Fertility Solutions
Market Need: Patent strategy coordination, trademark research and global registration, portfolio optimization, copyright protection, brand anti-counterfeiting programs
Our Approach: Collaborative IP development across global jurisdictions with 20+ years specialized experience in life sciences
Strategic Advantage: Strategic positioning through coordinated international filing and defensible IP portfolios
Nutraceutical Innovation Platform
Technology Foundation: Corporate structuring, shareholder agreements, contract drafting and negotiation, SOPs for international regulatory compliance, M&A transaction support
Current Pipeline: Legal partnerships with cross-border expertise essential for healthcare consultancy group operations, preparing frameworks for market access and possible new funding rounds.
Development Strategy: Streamlined governance through strategic legal collaboration, stakeholder-ready corporate foundations
Women's Health
Market Need: Financial planning and modeling, fundraising strategy, M&A advisory, valuation analysis, runway analysis, tax planning with international perspective
Our Approach: Financial top-tier competences and global alliance networking
Strategic Advantage: Hans P. Schmid brings 30+ years experience and track record in international pharmaceutical finance
Men's Health
Market Need: Increasing life expectancy (80+ years) drives demand for solutions sustaining vitality, performance, and healthy aging.
Our Approach: Science-backed products addressing male-specific health concerns from hormonal optimization to longevity support.
Strategic Advantage: Men’s health provider collaborations and B2B distribution channels in underserved market segments.
Why Partner with Adsidera:
30+ years pharmaceutical experience, 100+ licensing partnerships executed, multi-billion revenue generation track record. This isn’t first-time entrepreneurs we aim to support – this is seasoned executives applying proven methodologies to high-potential opportunities.
Scalable, Forward-Thinking Model
Pharmaceutical rigor meets modern engagement. Our approach combines regulatory excellence with digital innovation in healthcare, creating competitive advantages unavailable to traditional pharma companies or inexperienced startups.
Essential Market Services
Fertility, women’s health, men’s health represent fundamental human needs with growing demand and insufficient innovation. We’re not chasing trends – we’re addressing enduring market requirements.
Value-Driven Investment with Human Impact
Bold innovation in healthcare industry that transforms how people experience critical life stages. Commercial success aligned with meaningful improvement in quality of life.
Reliable, High-Potential Business Model
Proven team + validated market needs + clear commercial strategy + realistic financial projections = lower risk profile than typical pharma ventures.
Request Our Comprehensive Investor Deck
If you are interested in investing in our projects that combine strategic expertise with hands-on execution, we invite you to request and review our investor materials.